Rwanda and Senegal will host Africa’s first COVID-19 vaccine plants: what’s known so far, Prof David Walwyn - The Conversation - 27 October 2021

Posted on October 29, 2021

The lack of vaccine production capacity in African countries has been the subject of much concern and hand-wringing in the wake of the COVID-19 pandemic. It has become a particularly hot topic because of the gravely unequal access to COVID-19 vaccines between developed and developing countries.

Africa has limited capacity for vaccines production. Only Tunisia, Senegal, Egypt, Ethiopia, and South Africa have varying capabilities to produce and fill or finish vaccines. The largest and most integrated facility is the Biovac Institute in Cape Town.

Recently Pfizer signed a letter of intent with the institute for 100 million doses per annum. The deal covers the importation of the drug substance in bulk, the filling of vials, and the distribution of the product in Africa and elsewhere.

Read more: Rwanda and Senegal will host Africa’s first COVID-19 vaccine plants: what’s known so farThe Conversation, 27 October 2021

- Author Prof David Walwyn
Published by Marlene Mulder

Copyright © University of Pretoria 2022. All rights reserved.

FAQ's Email Us Virtual Campus Share Cookie Preferences